In vivo evaluation of 2′-deoxy-2′-[18F]fluoro-5- iodo-1-β-D-arabinofuranosyluracil ([18F]FIAU) and 2′-deoxy-2′-[18F]fluoro-5-ethyl-1-β-D- arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 6, 2007, Pages 822-829

  Alauddin, Mian M ^b   Shahinian, Antranic ^a   Park, Ryan ^a   Tohme, Michel ^a,c   Fissekis, John D ^a   Conti, Peter S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FEAU; FIAU; Gene expression; HSV tk; PET

Indexed keywords

2' DEOXY 2' FLUORO 5 ETHYL 1 BETA DEXTRO ARABINOFURANOSYLURACIL F 18; 2' DEOXY 2' FLUORO 5 IODO 1 BETA DEXTRO ARABINOFURANOSYLURACIL F 18; FLUORINE 18; TRACER; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; DIAGNOSTIC IMAGING; GENE; GENE EXPRESSION; HERPES SIMPLEX VIRUS TYPE 1 THYMIDINE KINASE GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MARKER GENE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SUICIDE GENE; WILD TYPE;

ANIMALS; ARABINOFURANOSYLURACIL; CARBON RADIOISOTOPES; DNA; FLUORINE RADIOISOTOPES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC TECHNIQUES; HUMANS; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYMIDINE KINASE;

EID: 34249021435     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0305-1     Document Type: Article

References (35)

1. Culver KW, Blaese RM. Gene therapy for cancer. Trends genet 1994;10:174-8.
2. Oldfield EH, Ram Zvi, Culver KW, Blease RM, DeVroom HL, Anderson WF. Clinical protocols: gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993;4:39-69.
3. Ram Z, Culver KW, Oshiro EM, Viola JJ, DeVroom HL, Otto E, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producing cells. Nat Med 1997;3:1354-61.
4. Urbain JC. Reporter genes and imagene. J Nucl Med 2001;42:106-9.
5. Culver KW, Ram Zvi, Wallbridge S, Ishi H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256:1550-2.
6. Moolten FL, Wells JM, Heyman RA, Evans RM. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther 1990;1:125-34.
7. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol 1999;26:371-6.
8. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 1999;96:2333-8.
9. Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 1999;59:5186-93.
10. Haberkorn U, Altmann A, Morr I, Knopf K, Germann C, Haeckel R, et al. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. J Nucl Med 1997;38:287-94.
11. Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, et al. Positron emission tomography-based imaging of transgene expression mediated by replication conditional, oncolytic herpes simplex virus type-1 mutant vectors of cancer. Cancer Res 2001;61:2983-95.
12. Tjuvajev JG, Stockhammar G, Desai R, Uehera H, Watanabe K, Gansbacher B, et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995;55:6126-32.
13. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998;58:4333-41.
14. Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, et al. Quantification of gene expression by imaging reporter gene expression in living animals. Nat Med 2000;6:933-7.
15. Barrio JR, Namavari M, Satyamurthy N, Srinivasan A, Herschman HR, Gambhir SS, et al. 8-[F-18]fluoroacyclovir: an in vivo probe for gene expression with PET. J Nucl Med 1996;37:193P.
16. 18F]-fluoropenciclovir: an improved reporter probe for imaging HSV-tk reporter gene expression in vivo using PET. J Nucl Med 2001;42:96-105.
17. Spadari S, Maga G, Focher F, Ciarrocchi G, Manservigi R, Arcamone F, et al. L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J Med Chem 1992;35:4214-20.
18. Watanabe KA, Richmond W, Hirota K, Lopez C, Fox JJ. Nucleosides 110. Synthesis and herpes virus activity of some 2′-fluoro-2′- deoxyarabinofuranosyl pyrimidine nucleosides. J Med Chem 1979;22:21-4.
19. 18F]FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 1996;23:787-92.
20. 18F]-FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 1998;25:175-80.
21. 18F]-FHBG for in vivo measurement of suicide gene expression with PET. J Nucl Med 2001;42:1682-90.
22. 2: a facile entry for 8-fluorguanine derivatives. J Org Chem 1996;61:6084-5.
23. 18F]-fluoroguanine derivatives: in vivo probes for imaging gene expression with PET. Nucl Med Biol 2000;27:157-62.
24. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of 2′-deoxy-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging 2002;1:74-81.
25. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, et al. Direct comparison of HSV-tk PET imaging probes: FIAU, FHPG, FHBG. J Nucl Med 2002;43:1072-83.
26. 14C]FIAU for imaging HSV1-tk reporter gene expression: adenoviral infection vs. stable transfection. Eur J Nucl Med Mol Imaging 2003;30:1547-60.
27. 18F]-FMAU). J Labelled Compd Radiopharm 2002;45:583-90.
28. 18F]fluoro-5-methyl-1-β-D- arabinofuranosyluracil and its 5-substituted nucleosides. J Labelled Compd Radiopharm 2003;46:285-9.
29. 18F]-FIAU), as potential PET agents for imaging cellular proliferation. Nucl Med Biol 2003;30:215-24.
30. Watanabe KA, Su T-L, Reichman U, Greenberg N, Lopez C, Fox JJ. Nucleosides 129. Synthesis of antiviral nucleosides: 5-Alkenyl 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracils. J Med Chem 1994;27:91-4.
31. Chou TC, Kong XB, Fanucchi MP, Cheng YC, Takahashi K, Watanabe KA, et al. Synthesis and biological effects of 2′-fluoro-5-ethyl-1-β-D- arabinofuranosyluracil. Antimicrob Agents Chemother 1987;31:1355-8.
32. Lyons RM, Forry-Schaudies S, Otto E, Wey C, Patilkoota V, Kaloss M, et al. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increasing antitumor efficacy in vivo. Cancer Gene Ther 1995;2:273-80.
33. Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D. Mechanism for ganciclovir resistance in gastrointestinal tumor cells transduced with retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin Cancer Res 1998;4:731-41.
34. Klecker RW, Kakti AG, Collins JM. Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2′-fluoro-2′- deoxy-β-D-arabinofuranosyl)-5-iodouracil in U937 and MOLT-4 cells. Mol Pharmacol 1994;46:1204-9.
35. 18F]-FFAU as a potential PET imaging agent for gene expression. J Nucl Med 2004;45:2063-9.